Crossmark

ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer

Published Online: 2023-01-25

Published Print: 2023-04

Authors

Nash, A. L.

Ren, Y.

Plichta, J. K.

Rosenberger, L. H.

van den Bruele, A. M. B.

DiNome, M. L.

Westbrook, K.

Hwang, E. Shelley https://orcid.org/0000-0002-8571-1148
License Information

Text and Data Mining valid from 2023-01-25

Version of Record valid from 2023-01-25
More Information

Article History

First Online: 25 January 2023

Disclosure

: E. Shelley Hwang is a consultant for Merck and Astra Zeneca and is on the Scientific Advisory Board for Clinetic.

Document is current